Berger Franklin M's Form 4 filing
Atea Pharmaceuticals, Inc. (AVIR) · filed Nov 15, 2022
- Accession no.
- 0000899243-22-035942
- Filed
- Nov 15, 2022
- Trade date
- Nov 11-14, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $214.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Berger Franklin MCIK 0001273885 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2022 | Common Stock | SSaleDisposed | −25,500 | $5.15 | −$131,325 | 794,519 | Direct | |
| Nov 14, 2022 | Common Stock | SSaleDisposed | −16,166 | $5.16 | −$83,416.56 | 778,353 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.